Ju Hoon Oh

Title: Innovations of Ju Hoon Oh in Pharmaceutical Chemistry

Introduction

Ju Hoon Oh is a prominent inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on biguanide derivatives. With a total of nine patents to his name, his research focuses on developing compounds that can effectively treat various health conditions.

Latest Patents

Ju Hoon Oh's latest patents include a biguanide derivative and a preparation method thereof, along with a pharmaceutical composition containing this derivative as an active ingredient. This compound, characterized by N1-N5 substitution, demonstrates remarkable effects on the activation of AMPKα and the inhibition of cancer cell proliferation at low doses. This innovation holds promise for treating diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, and cancer. Another notable patent involves N1-cyclic amine-N5-substituted biguanide derivatives, which also show potential in inhibiting cancer cell proliferation, metastasis, and recurrence through AMPK activation, even when administered in small doses.

Career Highlights

Throughout his career, Ju Hoon Oh has worked with notable companies such as Immunomet Therapeutics Inc. and Hanall Biopharma Co., Ltd. His work in these organizations has furthered the development of innovative pharmaceutical solutions.

Collaborations

Ju Hoon Oh has collaborated with esteemed colleagues, including Chang Hee Min and Yong Eun Kim, to advance his research and innovations in the pharmaceutical field.

Conclusion

Ju Hoon Oh's contributions to pharmaceutical chemistry, particularly through his patents on biguanide derivatives, highlight his role as a leading inventor in the industry. His work not only addresses critical health issues but also paves the way for future innovations in drug development.